Painchek (PCK) Stock Overview

PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia and internationally. The company offers PainChek, which uses camera in smartphones and tablets for facial scan that is analyzed in real time using facial recognition software to indicate the presence of the pain. It serves patients suffering with dementia and pre-verbal infants. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.

PCK Stock Information

Symbol

PCK

Address

35 Lime StreetSydney, NSW 2000Australia

Founded

Trading hours

10:00 AM - 4:00 PM AEST

Website

https://www.painchek.com

Country

🇦🇺 Australia

Phone Number

61 4 2125 2123

Painchek (PCK) Price Chart

Painchek Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.020972586799447947	N/A
Market Cap	$30.11M	N/A
Shares Outstanding	1.44B	27.26%
Employees	0	N/A
Shareholder Equity	668.13K	-86.15%

Valuation	2023	Change
P/S Ratio	22.83	N/A
P/B Ratio	45.07	N/A

Growth	2023	Change
Return on Equity	-7.6700	N/A

Earnings	2023	Change
Revenue	$1.32M	N/A
Earnings	-$5.12M	N/A
Gross Margin	0.3655	N/A
Operating Margin	-4.50	N/A
Net income margin	-3.89	N/A

Financial Strength	2023	Change
Total Assets	$1.89M	N/A
Cash on Hand	$1.70M	N/A
Debt to Equity	$2.15	739.61%
Current Ratio	$1.30	-64.03%